A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models - January 01, 2024

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

A_2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	842	878	209
Jun 2022	997	1026	181
Jul 2022	614	643	217
Aug 2022	576	596	150
Sep 2022	212	217	107
Oct 2022	186	194	69
Nov 2022	146	150	58
Dec 2022	126	127	34
Jan 2023	104	108	47
Feb 2023	169	172	53
Mar 2023	164	167	46
Apr 2023	104	105	36
May 2023	117	117	22
Jun 2023	164	167	42
Jul 2023	80	81	34
Aug 2023	45	46	27
Sep 2023	53	54	36
Oct 2023	51	51	25
Nov 2023	57	59	28
Dec 2023	51	52	31
Jan 2024	37	37	17
Feb 2024	83	87	36
Mar 2024	76	77	79
Total	5054	5211	1584